Racial Disparities in Community Outcomes Among Individuals with Schizophrenia and Cooccurring Substance Use Disorders

REFERENCES

• Bae, S., Brekke, J. S., & Bola, J. (2004). Ethnicity and treatment outcome variation in schizophrenia: A longitudinal study of community-based psychosocial rehabilitation interventions. The Journal of Nervous and Mental Disease, 192, 623–628.
   PubMed Web of Science ®Google Scholar
• Bell, M., Milstein, R., Beam-Goulet, J., Lysaker, P., & Cicchetti, D. (1992). The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale: Reliability, comparability, and predictive validity. Journal of Nervous and Mental Disease, 180, 723–728.
   PubMed Web of Science ®Google Scholar
• Bellack, A. S. (2006). Scientific and consumer models of recovery in schizophrenia: Concordance, contrasts, and implications. Schizophrenia Bulletin, 32, 432–442.
   PubMed Web of Science ®Google Scholar
• Benton, A., & Hamsher, K. (1978). Multilingual Aphasia Examination. Iowa City, IA: University of Iowa.
   Google Scholar
• Brandt, J. (1991). The Hopkins Verbal Learning Test: Development of a new verbal memory test with six equivalent forms. The Clinical Neuropsychologist, 5, 125–142.
   Google Scholar
• Brekke, J. S., Hoe, M., Long, J., & Green, M. F. (2007). How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin, 33, 1247–1256.
   PubMed Web of Science ®Google Scholar
• Busch, A. B., Lehman, A. F., Goldman, H., & Frank, R. G. (2009). Changes over time and disparities in schizophrenia treatment quality. Medical Care, 47, 199–207.
   PubMed Web of Science ®Google Scholar
• Cornblatt, B. A., Risch, N. J., Faris, G., Friedman, D., & Erienmeyer-Kimling, L. (1988). The Continuous Performance Test, identical pairs version (CP-IP). I. New findings about sustained attention in normal families. Psychiatry Research, 26(2), 223–238.
   PubMed Web of Science ®Google Scholar
• Cournos, F., McKinnon, K., & Sullivan, G. (2005). Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus. Journal of Clinical Psychiatry,6(Suppl. 6), 27–33.
   Google Scholar
• Degenhardt, L., & Hall, W. (2001). The association between psychosis and problematic drug use among Australian adults: Findings from the National Survey of Mental Health and Well-Being. Psychological Medicine, 31, 659–668.
   PubMed Web of Science ®Google Scholar
• Drake, R. E., O’Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34, 123–138.
   PubMed Web of Science ®Google Scholar
• Drake, R. E., Wallach, M. A., Alverson, H. S., & Mueser, K. T. (2002). Psychosocial aspects of substance abuse by clients with severe mental illnesses. The Journal of Nervous and Mental Disease, 190, 100–106.
   PubMed Web of Science ®Google Scholar
• Eack, S. M., & Newhill, C. E. (2012). Racial disparities in mental health outcomes after psychiatric hospital discharge among individuals with severe mental illness. Social Work Research, 1(36), 41–52.
   Google Scholar
• Eack, S. M., Bahorik, A. L., Newhill, C. E., Neighbors, H. W., & Davis, L.E. (2012). Interviewer-perceived honesty as a mediator of racial disparities in the diagnosis of schizophrenia. Psychiatric Services, 63(9), 875–880.
   PubMed Web of Science ®Google Scholar
• Feise, R. J. (2002). Do multiple outcome measures require p-value adjustment? BMC Medical Research Methodology, 2(8), 1–4.
   PubMedGoogle Scholar
• First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured Clinical Interview for Axes I and II DSM–IV Disorders—Patient edition (SCID–I/P). New York, NY: New York State Psychiatric Institute.
   Google Scholar
• Gold, J. M., Carpenter, C., Randolph, C., Goldberg, T. E., & Weinberger, D. R. (1997). Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry, 54(2), 159–165.
   PubMed Web of Science ®Google Scholar
• Green, M. F., Nuechterlein, J. G., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., … Marder, S. R. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH–MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry, 56, 301–307.
   Google Scholar
• Grella, C. E., & Stein, J. A. (2006). Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatric Services, 57, 1007–1015.
   PubMed Web of Science ®Google Scholar
• Guy, W. (1976). ECDEU assessment manual for psychopharmacology—revised: Clinical global impressions. Rockville, MD: National Institute of Mental Health.
   Google Scholar
• Haro, J. M., Kamath, S. A., & Ochoa, S. (2003). The Clinical Global Impression–Schizophrenia Scale: A simple instrument to measure diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica, 107, 16–23.
   Web of Science ®Google Scholar
• Heaton, R. K., Chelune, G. J., Taley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources.
   Google Scholar
• Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T., Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10, 388–398.
   PubMed Web of Science ®Google Scholar
• Jackson, J. S., Knight, K. M., & Rafferty, J. A. (2010). Race and unhealthy behaviors: Chronic stress, the HPA axis, and physical and mental disparities over the life course. American Journal of Public Health, 100, 933–939.
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.
   PubMed Web of Science ®Google Scholar
• Keefe, R. S. (2010). Neurocognition. In S. T. Stroup & J. A. Liberman (Eds.), Antipsychotic trials in schizophrenia (pp. 189–206). New York, NY: Cambridge University Press.
   Google Scholar
• Kopelowicz, A., Liberman, R. P., & Zarate, R. (2006). Recent advances in social skills training for schizophrenia. Schizophrenia Bulletin, 32, S12–S23.
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl, J., Zito, J. M., Buchanan, R. W., Soeken, K. L., & Lehman, A. F. (2003). Racial disparity in the pharmacological management of schizophrenia. Schizophrenia Bulletin, 29, 183–193.
   PubMed Web of Science ®Google Scholar
• Lafayette Instrument Company (1989). Grooved Pegboard Instruction Manual (Model 32025). Lafayette, IN: Author.
   Google Scholar
• Lehman, A., & Steinwachs, D. (1998). At issue: Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin, 24, 1–10.
   PubMed Web of Science ®Google Scholar
• Liberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., … Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–1223.
   PubMed Web of Science ®Google Scholar
• Longshore, D., Grills, C., & Annon, K. (1999). Effects of a culturally congruent intervention on cognitive factors related to drug-use recovery. Substance Use & Misuse, 34, 1223–1241.
   PubMed Web of Science ®Google Scholar
• Miller, W. R., & Rollnick, S. (2004). Talking oneself into change: Motivational interviewing, stages of change, and therapeutic process. Journal of Cognitive Psychotherapy, 18, 299–308.
   Google Scholar
• Minkoff, K., & Drake, R. E. (1991). New directions for mental health services: Dual diagnosis of major mental illness and substance use disorder. San Francisco, CA: Jossey-Bass.
   Google Scholar
• Mueser, K. T., Noordsy, D. L., Drake, R. E., & Fox, L. (2003). Integrated treatment for dual disorders: A guide to effective practice. New York, NY: Guilford.
   Google Scholar
• Neighbors, H. W., Caldwell, C., Williams, D. R., Nesse, R., Taylor, R. J., McKeever, K., … Jackson, J. S. (2007). Race, ethnicity, and the use of services for mental disorders: Results from the National Survey of American Life. Archives of General Psychiatry, 64, 485–494.
   PubMed Web of Science ®Google Scholar
• Neighbors, H. W., Trierweiler, S. J., Ford, B. C., & Muroff, J. R. (2003). Racial differences in DSM diagnosis using a semi-structured instrument: The importance of clinical judgment in the diagnosis of African Americans. Journal of Health and Social Behavior, 44(3), 237–256.
   PubMed Web of Science ®Google Scholar
• New Freedom Commission on Mental Health. (2003). Achieving the promise: Transforming mental health care in America (U.S. Department of Health and Human Services [HHS] Publication No. SMA-03-38-31). Rockville, MD: Author.
   Google Scholar
• Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., … Marder, S. R. (2008). The MATRICS Consensus Cognitive Battery, Part 1: Test selection, reliability and validity. American Journal of Psychiatry, 165, 203–213.
   PubMed Web of Science ®Google Scholar
• Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Welden, P. J. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51(2), 216–222.
   PubMed Web of Science ®Google Scholar
• Pincus, H. A., Spaeth-Rublee, B., & Watkins, K. E. (2011). The case for measuring quality in mental health and substance abuse care. Health Affairs, 30, 730–736.
   Web of Science ®Google Scholar
• Primm, A. B., Vasquez, M. J. T., Mays, R. A., Sammons-Posey, D., McKnight-Eily, L. R., Presley-Cantrell, L. R., … Perry, G. S. (2010). The role of public health in addressing racial and ethnic disparities in mental health and mental illness. Preventing Chronic Disease, 7, 1–7.
   Web of Science ®Google Scholar
• R Development Core Team. (2014). R: A language and environment for statistical computing (Version 2.15.0) [Computer software]. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Rapp, C. A., Saleebey, D., & Sullivan, P. W. (2005). The future of strengths-based social work. Advances in Social Work, 6, 79–90.
   Google Scholar
• Reiger, D., Farmer, M., Rae, D., Locke, B., Keith, S., Judd, L., … Goodwin, F. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemologic Catchment Area (ECA) Study. JAMA, 264, 2511–2518.
   PubMed Web of Science ®Google Scholar
• Rost, K., Hsieh, Y., Xu, S., Menachemi, N., & Young, A. S. (2011). Potential disparities in the management of schizophrenia in the United States. Psychiatric Services, 62, 613–617.
   PubMed Web of Science ®Google Scholar
• Snowden, L. R. (2012). Health and mental health policies’ role in better understanding and closing African American–White American disparities in treatment access and quality of care. American Psychologist, 67, 524–531.
   PubMed Web of Science ®Google Scholar
• Stroup, T. S., & Liberman, J. A. (2010). Antipsychotic trials in schizophrenia. New York, NY: Cambridge University Press.
   Google Scholar
• Stroup, T. S., McEvoy, J. P., Swartz, M. S., Bylery, M. J., Glick, I. D., Canive, J. M., … Liberman, J. A. (2003). The National Institute of Health Clinical Antipsychotic Trials of Intervention of Effectiveness (CATIE) project: Schizophrenia trial design and protocol development. Schizophrenia Bulletin, 29, 15–31.
   PubMed Web of Science ®Google Scholar
• Swartz, M. S., Wagner, R. H., Swanson, J. W., Stroup, S. T., McEvoy, J. P., McGee, M., … Liberman, J. A. (2006). Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. Psychiatric Services, 57, 1110–1116.
   PubMed Web of Science ®Google Scholar
• Trierweiler, S. J., Neighbors, H. W., Munday, C., Thompson, E. E., Binion, V. J., & Gomez, J. P. (2000). Clinician attributions associated with the diagnosis of schizophrenia in African American and non-African American patients. Journal of Consulting and Clinical Psychology, 68(1), 171–175.
   PubMed Web of Science ®Google Scholar
• Tsuang, J., & Fong, T. W. (2004). Treatment of patients with schizophrenia and substance abuse disorders. Current Pharmaceutical Design, 10, 2249–2261.
   PubMed Web of Science ®Google Scholar
• Volkow, N. (2009). Substance use disorders in schizophrenia—Clinical implications of comorbidity. Schizophrenia Bulletin, 35, 469–472.
   PubMed Web of Science ®Google Scholar
• Watson, A. C., & Eack, S. M. (2011). Oppression and stigma and their effects. In N. R. Heller and A. Gitterman (Eds.), Mental health and social problems: A social work perspective (pp. 22–43). London, UK: Routledge.
   Google Scholar
• Wechsler, D. (1981). WAIS-R Manual: Wechsler Adult Intelligence Scale—Revised. New York, NY: Psychological Corporation.
   Google Scholar
• Wechsler, D. (1991). Wechsler Intelligence Scale for Children (3rd Ed.). San Antonio, TX: Psychological Corporation.
   Google Scholar
• Whaley, A. L. (2001). Cultural mistrust and the clinical diagnosis of paranoid schizophrenia in African American patients. Journal of Psychopathology and Behavioral Assessment, 23, 93–100.
   Web of Science ®Google Scholar
• Woods, S. W. (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry, 64, 663–667.
   PubMed Web of Science ®Google Scholar
• Wu, L. T., Kouzis, A. C., & Leaf, P. J. (1999). Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. American Journal of Psychiatry, 156, 1230–1236.
   PubMed Web of Science ®Google Scholar
• Wu, L. T., Ringwalt, C. L., & Williams, C. E. (2003). Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatric Services, 54, 363–369.
   PubMed Web of Science ®Google Scholar
• Ziedonis, D. M., Smelson, D., Rosenthal, R. N., Batki, S. L., Green, A. I., Henry, R. J., … Weiss, R. D. (2005). Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice, 11, 315–339.
   PubMedGoogle Scholar